Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and S-1 in Heavily Treated Advanced Colorectal Cancer
NCT01929421Phase 2Completed
- Sponsor
- Gachon University Gil Medical Center
- Start
- Dec 2009
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, tegafur in colorectal cancer (CRC), sponsored by Gachon University Gil Medical Center. Started Dec 2009; status: completed.
02
Drugs
gemcitabinetegafur
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01929421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01929421.